Teva Pharma Industries Ltd ADR
Price & Volume
Stats
See more52W Range | $14.99-$37.35 |
Market Cap | $40.2B |
Shares Short | 26M |
Financials
See moreRevenue (12 Mos) | $17.3B |
Revenue Growth (YoY) | 2.3% |
Gross Profit (12 Mos) | $9B |
Diluted EPS | $1.34 |
News
See moreYahoo Finance • 11 days ago
Polymyositis Market Research Report 2026-2036: Competitive Landscape is Dominated by Major Players Such As Teva Pharmaceuticals, Gilead Sciences, Roche, AbbVie, and Pfizer
Yahoo Finance • 12 days ago
TrumpRx set to expand into generic medicines with Mark Cuban
Yahoo Finance • 12 days ago
Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution
Yahoo Finance • 14 days ago
Teva Pharmaceutical (TEVA) Reports Q1 Beat, Plans Amylyx Deal
About
CEO | Mr. Richard D. Francis |
CFO | Mr. Eliyahu Sharon Kalif |
Address | 124 Dvora HaNevi?a St., Tel Aviv-Yafo, Israel, 6944020 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 31,173 |